These results are in line with our expectations based on the literature, where in general, higher levels of SLC6A4 methylation result in lower SLC6A4 expression, which results in higher risk for depression and anxiety and reduced behavioral stress reactivity. Here, SLC6A4 is linked to depressive symptom measurement.